University of Turku
utu.fiTotal trials
119
Active
21
Phase 3
4
Total enrollment
138,731
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Anticoagulation Therapy | — | — | — | — | — | 1 |
Next readouts
- 2025-01-08
Top conditions
- Atrial Fibrillation10
- Healthy5
- Physical Activity4
- Coronary Artery Disease4
- Stroke3
- Dental Caries3
- Leadership3
- Cardiovascular Diseases3
Frequently asked questions about University of Turku
- How many clinical trials does University of Turku have on ClinicalTrials.gov?
- University of Turku is listed as the lead sponsor on 119 clinical trials in ClinicalTrials.gov, 21 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Turku's trials are in Phase 3?
- 4 of University of Turku's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University of Turku focus on?
- University of Turku's most-studied conditions on ClinicalTrials.gov are Atrial Fibrillation, Healthy, Physical Activity, Coronary Artery Disease, Stroke.
- When are University of Turku's next clinical trial readouts?
- University of Turku has 1 upcoming primary-completion readout tracked here; the soonest is “Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study”, expected around 2025-01-08.